Results of high dose vancomycin loaded spacers in treatment of infected massive prostheses

Communication sur le cancer

Results of high dose vancomycin loaded spacers in treatment of infected massive prostheses
association ametist

cancer de l'enfant L'ASSOCIATION
osteosarcome enfant
   lutte contre le cancer Accueil
   associations enfants cancer Pourquoi AMETIST ?
   association ostéosarcome Ses missions
   osteosarcome enfant Unité spécialisée
   association malades ostéosarcome Spécificité de l'Unité
   association de cancereux Ses actions
   osteosarcome enfant Actualités

cancer de l'enfant SOUTIENS
osteosarcome enfant
   association cancer Personnalités
   association cancer Témoignages
   association Témoignages Vidéos
   osteosarcome enfant Sites Internet

cancer de l'enfant ILS EN PARLENT
osteosarcome enfant
   aides diverses pour cancéreux Télévision
   oncologie pédiatrique Radios
   osteosarcome enfant Presse
   aide pour le cancer Médias Internet

association enfant cancer PARTICIPER
osteosarcome enfant
   cancer de l'enfant Devenir Membre
   association enfant cancer Faire un don
   association cancers Faire un lien

sarcome de ewing AMETIST ET VOUS
   sarcome ewing Nous contacter
   sarcome cancer Lettre d'information
   sarcome cancer FaceBook AMETIST

pétition enfants cancéreux

carine curtet
Témoignage Intégral de Carine Curtet
Présidente de l'Association AMETIST

vidéo nicole delepine
Témoignage Intégral du Dr Delépine
Pour le film Cancer Business Mortel

vidéo nicole delepine
vidéo nicole delepine

soutien associaiton cancer

Si vous souhaitez contacter Nicole Delepine
Rendez-vous sur son site :
site de Nicole Delépine

information cancer et médecine

Results of high dose vancomycin loaded spacers in treatment of infected massive prostheses - 10th EFORT Congress, 3-6 June 2009 Vienna et Séminaire du Groupe ethique et médicament du 13 juin au Centre Hospitalier Universitaire Raymond Poincaré

Delepine G Delepine F Lankri Z Alkhallaf S Delepine N


- With the dramatic improvement of conservative surgery in patients with bone sarcoma infection becomes the most devastating complication, leading frequently to amputation.

The aim of this monocentric study

- is to precise the influence of spacer loaded with high doses of Vancomycin on late results.

- High dose Vancomycin means at least 4 grams (4grams vancomycine per batch of 40 grams of methacrylate)


- From 1984 to 2007, we operated more than 600 patients with bone sarcoma.

- Age : 4,5 to 82 years (mean 25 y)

- . Histology : osteosarcoma (304), Ewing (142), chondrosarcomas (148), fibrosarcomas or MFH (23), giant cell tumours in others.

- Out 484 cases, patients received chemotherapy, and radiotherapy in 50


- The mean follow-up from tumour removal is 15 years.

57 p suffered of deep infection of the material used to reconstruct the skeletal defect.

- We saw also 3 p for recurrence of deep infection initially treated elsewhere. Altogether, we treated 60 patients for deep infections.

Treatment of infection: amputation

- Life threatening septicemia or inability to obtain a muscle coverage compelled to primarly amputate 4 patients.

Radioinduced osteosarcoma of astragalus resection.. Skin necrosis.. Failure of muscular flap. Amputation

Conservative treatment

- 26 p had debridment and cleaning of the prosthesis and long adapted antibiotherapy as first treatment.

- When ineffective (23/26), a removal of the prosthesis was performed with immediate replacing the new prosthesis in 19 cases.

Infection are often linked with insufficient coverage

All these patients benefited of muscular flap

53 patients with a two stages protocol including spacers

- When infection recurred (16/19) and in all other patients the treatment included a two stages protocol with interposition of a spacer with antibiotic loaded cement during 4 to 12 weeks .

- The new prosthesis was placed in a later time, when infection, cutaneous and muscular problems were solved

Doses of vancomycin

- 1984-1990 the spacer was made with gentamycin containing cement (palacos)

- 1990-2004 spacer added mixed with conventional doses of antibiotics (vanco, rifadin, tobra) adapted to the germ resitance.

- From 2004/6 we used high doses of vancomycin (4 g per batch of 40 g) with an average total dose of 11g of vancomycin per spacer.


- At the last control, 15 were amputated, following a mean of 6 ineffective procedures

- 45 p. benefited from conservation surgery but a new prosthesis could be inserted only in 43, following a mean of 3.2 surgical procedures


- Shows the bad prognostic value of

- initial radiotherapy,

- distal locations,

- insufficient muscular coverage

- the better efficacy of spacers loaded with high dose antibiotics

Pejorative vale of irradiation

- statistical analysis show the higher risk of amputation for Irradiated Patients

- 11 amputations / 22 irradiated patients

- versus 4 of 38 non irradiated patients

Radiotherapy increases the risk

Radioinduced osteosarcoma of scapula treated by resection and prosthesis.Skin necrosis 3 weeks after

Prognostic value of Vancomycine to avoid amputation

- 10 amputations for 23 spacers without Vancomycine

- versus 5 of 37 patients with Vancomycine).

Crucial value of High dose Vancomycine to avoid amputation

Up to date, none of the high dose antibiotic loaded spacers was followed by amputation

High dose vanco can cure infection with various germs

- All infections with staphylococcus aureus have been cured.(even "resistant" staph).

- But also most of infection with other bacterie supposed to be vancomycin resistant on classical antibiograms

- Usual antibiogram do not study the high level of vanco observed around high dose spacers


- Infection of massive prostheses is the most serious orthopaedic complication of limb salvage.

- Treatment must be preventive, avoiding any radiotherapy.

Good prognostic factors are early removal of the prosthesis, effective antibiotherapy, improvement of the muscular coverage, and use of spacers with high dose vancomycin.

cancer Consulter le document dans sa version complète tumeur

ostéocarcome sarcome ewing

traitement sarcome ewing
Accueil | L'association | Faire un Don | Actualités | Actions | Contacts | Sarcomes | Nicole Delépine | Info cancer | Plan du site | Mentions Légales | Webangelis